Question 1

What is Magnet Biomedicine's technology?

Accepted Answer

Magnet Biomedicine's modular TrueGlue™ technology enables the systematic discovery of molecular glues towards the treatment of human disease. TrueGlues are specialized small molecule therapeutics that induce proximity between a disease-relevant target and a "presenter" protein, resulting in novel presenter-dependent biology.

Question 2

What are the potential benefits of TrueGlues?

Accepted Answer

TrueGlues offer the potential to deliver therapies for even the most intractable targets and to achieve other desirable but challenging translational goals, such as overcoming limitations in ligandability of target proteins, providing tissue specificity to minimize on-target-off-tissue toxicity, and enabling glue inhibitors of cytokines/receptors to substitute oral small molecules for injectable biologics.

Question 3

What is the science behind Magnet Biomedicine's technology?

Accepted Answer

When a TrueGlue binds to a presenter protein, a neo-PPI interface is created, mediating the formation of a ternary complex with a disease target protein, and resulting in presenter-dependent engagement of the target protein.

Question 4

What are the potential applications of Magnet Biomedicine's technology?

Accepted Answer

Magnet Biomedicine's TrueGlue™ technology has the potential to advance precision medicine by enabling the systematic discovery of molecular glues for the treatment of a wide range of human diseases.

Voyager DB

Contact Research

People Search

Chrome Extension

Integrations

Magnet Biomedicine

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Employees

Established

About Magnet Biomedicine

Business Profile

About the website